Safety pharmacology investigates the unintended pharmacological effects of potential drugs that could pose a hazard, especially to vulnerable populations. This volume details the regulatory requirements for safety pharmacology studies and the scientific justification behind them. Drawing on over 30 years of experience, the author provides practical insights into conducting these studies effectively and understanding the reasons for their failure.

The book is structured to provide practical guidance for professionals in pharmaceutical development, leveraging the author's extensive experience. Its focus on both regulatory mandates and the practicalities of study execution suggests it serves as a valuable resource for researchers and developers navigating the complexities of drug safety assessment. The inclusion of 'tricks and practical insights' indicates an aim to offer actionable advice beyond theoretical principles.